Paclitaxel and High-Dose Oral Estramustine in Patients with Hormone-Refractory Prostate Carcinoma

Source :: Clinical Oncology Alert. August 1, 2001
Publication Year :: 2001
Abstract: Paclitaxel and High-Dose Oral Estramustine in Patients with Hormone-Refractory Prostate Carcinoma ABSTRACT & COMMENTARY Synopsis: Weekly paclitaxel chemotherapy combined with 3 days of high-dose oral estramustine was evaluated in a [...]

Subjects :: Prostate cancer -- Care and treatment
Cancer patients -- Care and treatment
Carcinoma -- Care and treatment
Cancer -- Care and treatment
Paclitaxel -- Dosage and administration
Health

Tools